Piper Sandler raises AbbVie (NYSE:ABBV) price target from $163 to $170

By / / Abbvie, Piper Sandler

Piper Sandler analyst Christopher Raymond maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $163 to $170.

Scroll to Top